This topic contains a solution. Click here to go to the answer

Author Question: When a monopolizer is emerging, the leader can challenge the group's structure by a. opening the ... (Read 30 times)

Arii_bell

  • Hero Member
  • *****
  • Posts: 596
When a monopolizer is emerging, the leader can challenge the group's structure by
 
  a. opening the floor to new speakers by announcing that the group would like to hear from someone who has not yet spoken on the issue.
  b. telling the monopolizer he/she cannot answer questions until everyone else has answered at least once.
  c. excusing the member from the group since he/she does not need counseling if he/she is sure of the information the group is learning.
  d. All of the above.

Question 2

An individual may outperform the group when it is
 
  a. A disjunctive task
  b. A conjunctive task
  c. An additive task
  d. A maximizing task



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

aham8f

  • Sr. Member
  • ****
  • Posts: 336
Answer to Question 1

a

Answer to Question 2

A




Arii_bell

  • Member
  • Posts: 596
Reply 2 on: Jul 31, 2018
Gracias!


alvinum

  • Member
  • Posts: 317
Reply 3 on: Yesterday
Thanks for the timely response, appreciate it

 

Did you know?

The senior population grows every year. Seniors older than 65 years of age now comprise more than 13% of the total population. However, women outlive men. In the 85-and-over age group, there are only 45 men to every 100 women.

Did you know?

Cucumber slices relieve headaches by tightening blood vessels, reducing blood flow to the area, and relieving pressure.

Did you know?

Prostaglandins were first isolated from human semen in Sweden in the 1930s. They were so named because the researcher thought that they came from the prostate gland. In fact, prostaglandins exist and are synthesized in almost every cell of the body.

Did you know?

In Eastern Europe and Russia, interferon is administered intranasally in varied doses for the common cold and influenza. It is claimed that this treatment can lower the risk of infection by as much as 60–70%.

Did you know?

Before a vaccine is licensed in the USA, the Food and Drug Administration (FDA) reviews it for safety and effectiveness. The CDC then reviews all studies again, as well as the American Academy of Pediatrics and the American Academy of Family Physicians. Every lot of vaccine is tested before administration to the public, and the FDA regularly inspects vaccine manufacturers' facilities.

For a complete list of videos, visit our video library